Lrp1B Protein Ldl Receptor Related Protein 1B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Lrp1B Protein Ldl Receptor Related Protein 1B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LRP1B (LDL Receptor-Related Protein 1B) is a member of the LDL receptor family, closely related to [LRP1](/proteins/lrp1). It is a large endocytic receptor expressed predominantly in the brain and various tissues. LRP1B functions as a tumor suppressor and is implicated in Alzheimer's disease pathogenesis through its role in [amyloid-beta](/proteins/amyloid-beta) clearance and neuronal signaling.
Structure
LRP1B is a large transmembrane protein with the following architecture:
Extracellular Domain
Ligand-binding repeats: 32-33 complement-type repeats that bind various ligands
Epidermal growth factor (EGF) precursor homology domain: Contains EGF-like repeats and spacer regions
O-linked sugar domain: Threonine/serine-rich region
Transmembrane Domain
Single pass transmembrane helix: Spans the plasma membrane
Cytoplasmic Domain
NPXY motifs: Two NPXY endocytosis signals in the cytoplasmic tail
Other signaling motifs: Phosphorylation sites for signal transduction
The protein has a molecular weight of ~600 kDa, making it one of the largest cell surface receptors.
Function
Endocytic Receptor
LRP1B functions as a scavenger receptor:
Ligand internalization: Binds and internalizes various ligands including:
[Apolipoprotein E](/proteins/apoe) (apoE)
Amyloid-beta (Aβ) peptides
Alpha-2-macroglobulin
Tissue-type plasminogen activator (tPA)
Various other proteins
Receptor recycling: Efficient recycling back to the cell surface
Lysosomal targeting: Directs ligands for degradation
Neuronal Function
In the brain, LRP1B plays important roles:
Amyloid-beta clearance: Mediates neuronal uptake and clearance of Aβ
Synaptic function: Regulates synaptic plasticity and memory
Axonal transport: Involved in intracellular trafficking
Neuroprotection: Protective against toxic protein aggregates
Signaling Receptor
LRP1B participates in multiple signaling pathways:
MAPK/ERK signaling: Activation of proliferative pathways
PI3K/Akt signaling: Cell survival pathways
Wnt signaling: Cross-talk with developmental pathways
Tissue Expression
Brain: High expression in [neurons](/entities/neurons), particularly [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
Lung: Bronchial epithelium
Testis: Germ cells
Lower expression: Heart, kidney, liver
Role in Neurological Disease
Alzheimer's Disease
LRP1B has significant implications in AD pathogenesis:
Amyloid-beta metabolism
Mediates neuronal clearance of Aβ40 and Aβ42
Implicated in Aβ uptake and degradation
Dysregulation contributes to amyloid plaque formation
Genetic associations
LRP1B polymorphisms linked to late-onset AD risk
Expression changes in AD brain tissue
Interaction with APOE alleles
Therapeutic target
LRP1B modulators being explored for AD treatment
Gene therapy approaches under investigation
Parkinson's Disease
Emerging evidence suggests roles in PD:
May interact with [alpha-synuclein](/proteins/alpha-synuclein) clearance pathways
Expression altered in PD substantia nigra
Potential neuroprotective functions
Cancer
LRP1B functions as a tumor suppressor:
Frequent deletions: Lost in various cancers (lung, bladder, breast)
[LRP1B in cancer (2019)](https://doi.org/10.1158/1541-7786.MCR-19-0123)
Background
The study of Lrp1B Protein Ldl Receptor Related Protein 1B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, LRP1B: a tumor suppressor and Alzheimer's disease gene (2019) (2019)](https://doi.org/10.1158/1541-7786.MCR-19-0123)
[Unknown, LRP1B in amyloid-beta clearance (2020) (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.03.015)
[Unknown, LDL receptor family in neurodegeneration (2021) (2021)](https://doi.org/10.1007/s00401-021-02291-4)
[Unknown, LRP1 and LRP1B in Alzheimer's disease (2018) (2018)](https://doi.org/10.1111/jnc.14345)